DEMONSTRATE Trial Evaluates Machine Learning Platform for Opioid Overdose Prevention in Primary Care — Implementation Study Results Due 2026
247 Health News Editorial
·15 Apr 2026
·3 min read
·clinical-trialsThe DEMONSTRATE trial evaluates a machine learning platform that alerts primary care physicians to patients at high risk of opioid overdose. Results from this 674-participant implementation study could transform opioid safety in primary care settings.
Originally reported by ClinicalTrials.gov
References
- 1.University of Pittsburgh. (2024). Developing and Evaluating a Machine-Learning Opioid Prediction & Risk-Stratification E-Platform (DEMONSTRATE) [Clinical trial registration NCT06810076
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service